JAZZ News and Press, Jazz Pharmaceuticals plc From 05/05/21

Jazz Pharmaceuticals Completes Acquisition of GW Pharmaceuticals plc PR Newswire DUBLIN , May 5, 2021 /PRNewswire/ -- Jazz Pharmaceuticals (Nasdaq: JAZZ) today announced the completion of its acquisition of GW Pharmaceuticals plc (Nasdaq: GWPH) ("GW"), a lea...

Jazz Pharmaceuticals plc (JAZZ) Q1 2021 Results Earnings Conference Call May 4, 2021, 04:30 PM ET Company Participants Andrea Flynn - Head of Investor Relations Bruce Cozadd - Chairman and Chief Executive Officer Daniel Swisher, Jr. - President and Chief Operating Officer Robert Iannone - Exe...

The following slide deck was published by Jazz Pharmaceuticals plc in conjunction with their 2021 Q1 earnings call. For further details see: Jazz Pharmaceuticals plc 2021 Q1 - Results - Earnings Call Presentation

Image source: The Motley Fool. Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) Q1 2021 Earnings Call May 4, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Jazz Pharmaceuticals PLC (JAZZ) Q1 2021 Earnings Call Transcript

Jazz Pharmaceuticals to Participate in Three Investor Conferences in May 2021 PR Newswire DUBLIN , May 4, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that its senior management team will provide a company overview and business and...

Jazz Pharmaceuticals (JAZZ): Q1 Non-GAAP EPS of $3.92 beats by $0.19; GAAP EPS of $2.09 misses by $0.74.Revenue of $607.58M (+13.6% Y/Y) misses by $1.74M.FY 2021 total revenue guidance affirmed at $2.55B-2.70B vs. consensus of $2.69BPress Release For further details see: Jazz Pharmaceut...

Jazz Pharmaceuticals Announces First Quarter 2021 Financial Results Strong Xywav™ Adoption With 3,900 Active Xywav Patients Exiting The First Quarter Continued Zepzelca™ Growth Across Second-Line SCLC Setting Xywav in Idiopathic Hypersomnia Granted FDA Prio...

Jazz Pharmaceuticals Announces Closing of Senior Secured Notes Offering PR Newswire DUBLIN , April 29, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) (the "Company" or "Jazz") today announced the closing of its previously announced offering (th...

Riding powerful fundamental improvement, ImmunoGen has made strong turnaround progress. With the upcoming data release for SORAYA and MIRASOL, you can expect ImmunoGen to break the bearish trend to trade higher. This turnaround stock will likely reward you with substantial upside ...

The Medicinal  Cannabis Industry In May As the cannabis industry grows the medicinal use of marijuana will play a big role in the future of the market. According to BDSA global cannabis sales reached an estimated $21.3 billion in 2020 an increase of 48% compared to 2019. By 2026 BD...